Long COVID continues to impose a significant economic burden on the United States, with an estimated cost exceeding $8 billion between 2025 and 2027. This persistent condition, characterized by lingering symptoms like fatigue and shortness of breath, affects millions of Americans and results in substantial productivity losses for employers. Despite the growing impact, federal funding for long COVID research has been cut, and specialized treatment clinics are scarce, leaving a gap in national strategy and effective management. AI
Summary written by gemini-2.5-flash-lite from 1 sources. How we write summaries →
RANK_REASON The article discusses a significant ongoing economic impact and policy decisions regarding federal funding for a major public health issue. [lever_c_demoted from significant: ic=1 ai=0.0]
